NRx Non Currrent Assets Other from 2010 to 2024
| NRXPW Stock | USD 0.05 0 3.59% |
Non Currrent Assets Other | First Reported 2017-09-30 | Previous Quarter 384 K | Current Value 356 K | Quarterly Volatility 218.1 K |
Check NRx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRx Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 K, Interest Expense of 114 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRx financial statements analysis is a perfect complement when working with NRx Pharmaceuticals Valuation or Volatility modules.
NRx | Non Currrent Assets Other |
Latest NRx Pharmaceuticals' Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of NRx Pharmaceuticals over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. NRx Pharmaceuticals' Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRx Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
NRx Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | 62,137 | |
| Coefficient Of Variation | 270.37 | |
| Mean Deviation | 101,237 | |
| Median | 29,443 | |
| Standard Deviation | 168,001 | |
| Sample Variance | 28.2B | |
| Range | 686.6K | |
| R-Value | 0.47 | |
| Mean Square Error | 23.8B | |
| R-Squared | 0.22 | |
| Significance | 0.08 | |
| Slope | 17,476 | |
| Total Sum of Squares | 395.1B |
NRx Non Currrent Assets Other History
About NRx Pharmaceuticals Financial Statements
NRx Pharmaceuticals investors use historical fundamental indicators, such as NRx Pharmaceuticals' Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NRx Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 431 K | 452.6 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NRx Stock Analysis
When running NRx Pharmaceuticals' price analysis, check to measure NRx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRx Pharmaceuticals is operating at the current time. Most of NRx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRx Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.